Skip to Content

144 (Dutrebis lamivudine 150 mg / raltegravir 300 mg)

Generic Name: lamivudine/raltegravir

Pill with imprint 144 is Green, Elliptical / Oval and has been identified as Dutrebis lamivudine 150 mg / raltegravir 300 mg. It is supplied by Merck & Co., Inc..

Dutrebis is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Dutrebis lamivudine 150 mg / raltegravir 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 144

Dutrebis

Generic Name:
lamivudine/raltegravir
Imprint:
144
Strength:
lamivudine 150 mg / raltegravir 300 mg
Color:
Green
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Merck & Co., Inc.
National Drug Code (NDC):
00006-3054

Get help with Imprint Code FAQs.

More about Dutrebis (lamivudine / raltegravir)

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide